Grégoire Prévôt

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

Athénaïs Boucly, Jason Weatherald, Laurent Savale et al. · European Respiratory Journal · 2017 · 685 citations · Full text

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome

Vincent Cottin, Jérôme Le Pavec, Grégoire Prévôt et al. · European Respiratory Journal · 2009 · 478 citations · Full text

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Myriam Delaunay, J. Cadranel, Amélie Lusque et al. · European Respiratory Journal · 2017 · 416 citations · Full text

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini et al. · The Lancet Respiratory Medicine · 2017 · 262 citations

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study

Xavier Jaïs, Philippe Brénot, Hélène Bouvaist et al. · The Lancet Respiratory Medicine · 2022 · 202 citations

Thrombosis, Pulmonary Embolism, Hypertension +12